CHICAGO -- Electronic nudges increased uptake of flu vaccines among patients with a history of acute myocardial infarction ...

We are also eligible to receive up to $700 million in additional milestone payments related to our COVID-19 vaccine and ...

A collaboration with Sanofi offers flexibility and potential growth, allowing Novavax to focus on developing a COVID-19/influenza combination (CIC) and seasonal influenza vaccines. Despite ...

B.Riley Financial analyst Mayank Mamtani has maintained their bullish stance on NVAX stock, giving a Buy rating on November 13.Don't Miss our ...

3, KP.3.1.1 and LB.1. The company also recently entered into a licensing agreement worth over $1.2bn with Sanofi to ...

The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...

Critics say that, if RFK Jr. is made secretary of the HHS, a radical antiestablishment medical movement with roots in past centuries would take power.

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

Novavax Inc (NVAX) reports increased product sales and a strong cash position, while revising revenue guidance and navigating ...

influenza. "This merger helped the two companies gain leverage in the market, taking advantage of synergies to cut costs and increase development." On 6 May 2011, Sanofi-Aventis simplified its ...

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...